Chloroquine and hydroxychloroquine as available weapons to fight COVID-19

Objective: to map the literature on mental illness in the general population and in health professionals during the Covid-19 pandemic Method: a scoping review in the MEDLINE / PubMed, SCOPUS, Web of Science, PsycINFO, Science Direct databases and in the medRxiv, bioRxiv and PsyArXiv preprint servers, using the descriptors "Covid-19", "coronavirus infection", "coronavirus", "2019-nCoV", "2019 novel coronavirus disease", "SARS-CoV-2", "health personnel", "general public"and "mental health" Results: 1,168 articles were found, of which 27 were analyzed 19 (70%) dealt with the prevalence of mental illness in the general population, six (22%) in doctors and nurses, one (4%) in other health professionals and one (4%) in the general population and nurses 19 symptoms of mental illness were identified Conclusion: the Covid-19 pandemic triggered, more frequently, anxiety, depression, stress and post-traumatic stress disorders in the general population and health professionals Women, students and nurses are among the most affected Objetivo: mapear a literatura sobre adoecimento mental na população geral e em profissionais de saúde durante a pandemia da Covid-19 Método: scoping review nas bases de dados MEDLINE/PubMed, SCOPUS, Web of Science, PsycINFO, Science Direct e nos servidores de preprints medRxiv, bioRxiv e PsyArXiv, usando os descritores "Covid-19", "coronavirus infection", "coronavirus", "2019-nCoV", "2019 novel coronavirus disease", "SARS-CoV-2", "health personnel", "general public"e "mental health" Resultados: foram encontrados 1 168 artigos, dos quais 27 foram analisados 19 (70%) versaram sobre a prevalência de adoecimento mental na população geral, seis (22%) em médicos e enfermeiros, um (4%) nos demais profissionais de saúde e um (4%) na população geral e enfermeiros Identificaram-se 19 sintomas de adoecimento mental Conclusão: a pandemia da Covid-19 desencadeou, com maior frequência, ansiedade, depressão, estresse e transtornos do estresse pós-traumático na população geral e em profissionais de saúde Mulheres, estudantes e enfermeiros estão entre os mais acometidos

[1]  T. Bestebroer,et al.  Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture , 2014, Antimicrobial Agents and Chemotherapy.

[2]  I. Spyridopoulos,et al.  Involvement of cardiovascular system as the critical point in coronavirus disease 2019 (COVID-19) prognosis and recovery , 2020, Hellenic Journal of Cardiology.

[3]  D. Raoult,et al.  Azithromycin Inhibits the Replication of Zika Virus , 2018 .

[4]  P. Maes,et al.  Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice , 2009, Antimicrobial Agents and Chemotherapy.

[5]  D. Raoult,et al.  Treatment of classic Whipple's disease: from in vitro results to clinical outcome. , 2014, The Journal of antimicrobial chemotherapy.

[6]  D. Raoult,et al.  Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century , 2007, International Journal of Antimicrobial Agents.

[7]  Science multicenter collaboration group of Department of,et al.  [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. , 2020, Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases.

[8]  D. Raoult,et al.  Bactericidal effect of doxycycline associated with lysosomotropic agents on Coxiella burnetii in P388D1 cells , 1990, Antimicrobial Agents and Chemotherapy.

[9]  Jianjun Gao,et al.  Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. , 2020, Bioscience trends.

[10]  H. Shirasawa,et al.  Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK , 2007, Antiviral Research.

[11]  E. De Clercq,et al.  Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. , 2006, Journal of medicinal chemistry.

[12]  Marc Van Ranst,et al.  In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine , 2004, Biochemical and Biophysical Research Communications.

[13]  D. Barnard,et al.  Evaluation of Immunomodulators, Interferons and Known in Vitro SARS-CoV Inhibitors for Inhibition of SARS-Cov Replication in BALB/c Mice , 2006, Antiviral chemistry & chemotherapy.

[14]  Wu Zhong,et al.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.

[15]  F. Fenollar,et al.  Whipple's disease. , 2007, The New England journal of medicine.

[16]  Philippe Colson,et al.  Chloroquine for the 2019 novel coronavirus SARS-CoV-2 , 2020, International Journal of Antimicrobial Agents.

[17]  N. Seidah,et al.  Chloroquine is a potent inhibitor of SARS coronavirus infection and spread , 2005, Virology Journal.

[18]  T. Takano,et al.  Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo , 2013, Antiviral Research.

[19]  Md Abdul Alim Al-Bari,et al.  Chloroquine analogues in drug discovery: new directions of uses, mechanisms of actions and toxic manifestations from malaria to multifarious diseases , 2015, The Journal of antimicrobial chemotherapy.

[20]  Sukhdev Singh,et al.  COVID-19: The Case of Three Patients with the Same Diagnosis but Different Clinical and Laboratory Features , 2020, Case reports in medicine.

[21]  Kazi Faizul Azim,et al.  Screening and druggability analysis of some plant metabolites against SARS-CoV-2: An integrative computational approach , 2020, Informatics in Medicine Unlocked.

[22]  D. Raoult,et al.  Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. , 1999, Archives of internal medicine.

[23]  Jean-Marc Rolain,et al.  Antibiotic Susceptibility of Tropheryma whipplei in MRC5 Cells , 2004, Antimicrobial Agents and Chemotherapy.

[24]  M. Toumi,et al.  Commentary on “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial” by Gautret et al , 2020, Journal of market access & health policy.

[25]  Roberto Cauda,et al.  New insights into the antiviral effects of chloroquine , 2006, The Lancet Infectious Diseases.

[26]  A. Sposito,et al.  Diacerein: A potential multi-target therapeutic drug for COVID-19 , 2020, Medical Hypotheses.